Cargando…

LGG-59. Identifying hidden drivers of low-grade glioma tumor growth

Genomic drivers of pediatric low-grade gliomas (pLGGs) converge on alterations that activate the MAPK pathway. However, expression of individual driver oncogenes fails to induce tumor formation with high penetrance and, paradoxically, expression of these oncogenes suppresses growth in vitro. This, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Misek, Sean, Fultineer, Aaron, Condurat, Alexandra, Zhou, Kevin, Root, David, Persky, Nicole, Boehm, Jesse, Bandopadhayay, Pratiti, Beroukhim, Rameen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165109/
http://dx.doi.org/10.1093/neuonc/noac079.370
_version_ 1784720309812723712
author Misek, Sean
Fultineer, Aaron
Condurat, Alexandra
Zhou, Kevin
Root, David
Persky, Nicole
Boehm, Jesse
Bandopadhayay, Pratiti
Beroukhim, Rameen
author_facet Misek, Sean
Fultineer, Aaron
Condurat, Alexandra
Zhou, Kevin
Root, David
Persky, Nicole
Boehm, Jesse
Bandopadhayay, Pratiti
Beroukhim, Rameen
author_sort Misek, Sean
collection PubMed
description Genomic drivers of pediatric low-grade gliomas (pLGGs) converge on alterations that activate the MAPK pathway. However, expression of individual driver oncogenes fails to induce tumor formation with high penetrance and, paradoxically, expression of these oncogenes suppresses growth in vitro. This, combined with the non-monotonic tumor growth rate in patients, suggests that there are “hidden drivers” beyond a single driver oncogene that are necessary to support tumor growth. The goal of this project is to leverage high-throughput functional genomics strategies to identify these hidden drivers of pLGG. Our preliminary data indicates that genes which modulate differentiation are required for the survival of LGG cells, suggesting that these genes may be hidden drivers of LGG tumor growth. Additionally, we hypothesize that secreted factors in the tumor microenvironment regulate pLGG tumor growth, potentially by modulating differentiation. In total, genes which cooperate with pLGG driver oncogenes to promote tumor growth may represent a new class of therapeutic targets and may explain the complex patterns of tumor growth that are observed in patients.
format Online
Article
Text
id pubmed-9165109
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91651092022-06-05 LGG-59. Identifying hidden drivers of low-grade glioma tumor growth Misek, Sean Fultineer, Aaron Condurat, Alexandra Zhou, Kevin Root, David Persky, Nicole Boehm, Jesse Bandopadhayay, Pratiti Beroukhim, Rameen Neuro Oncol Low Grade Glioma Genomic drivers of pediatric low-grade gliomas (pLGGs) converge on alterations that activate the MAPK pathway. However, expression of individual driver oncogenes fails to induce tumor formation with high penetrance and, paradoxically, expression of these oncogenes suppresses growth in vitro. This, combined with the non-monotonic tumor growth rate in patients, suggests that there are “hidden drivers” beyond a single driver oncogene that are necessary to support tumor growth. The goal of this project is to leverage high-throughput functional genomics strategies to identify these hidden drivers of pLGG. Our preliminary data indicates that genes which modulate differentiation are required for the survival of LGG cells, suggesting that these genes may be hidden drivers of LGG tumor growth. Additionally, we hypothesize that secreted factors in the tumor microenvironment regulate pLGG tumor growth, potentially by modulating differentiation. In total, genes which cooperate with pLGG driver oncogenes to promote tumor growth may represent a new class of therapeutic targets and may explain the complex patterns of tumor growth that are observed in patients. Oxford University Press 2022-06-03 /pmc/articles/PMC9165109/ http://dx.doi.org/10.1093/neuonc/noac079.370 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Low Grade Glioma
Misek, Sean
Fultineer, Aaron
Condurat, Alexandra
Zhou, Kevin
Root, David
Persky, Nicole
Boehm, Jesse
Bandopadhayay, Pratiti
Beroukhim, Rameen
LGG-59. Identifying hidden drivers of low-grade glioma tumor growth
title LGG-59. Identifying hidden drivers of low-grade glioma tumor growth
title_full LGG-59. Identifying hidden drivers of low-grade glioma tumor growth
title_fullStr LGG-59. Identifying hidden drivers of low-grade glioma tumor growth
title_full_unstemmed LGG-59. Identifying hidden drivers of low-grade glioma tumor growth
title_short LGG-59. Identifying hidden drivers of low-grade glioma tumor growth
title_sort lgg-59. identifying hidden drivers of low-grade glioma tumor growth
topic Low Grade Glioma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165109/
http://dx.doi.org/10.1093/neuonc/noac079.370
work_keys_str_mv AT miseksean lgg59identifyinghiddendriversoflowgradegliomatumorgrowth
AT fultineeraaron lgg59identifyinghiddendriversoflowgradegliomatumorgrowth
AT conduratalexandra lgg59identifyinghiddendriversoflowgradegliomatumorgrowth
AT zhoukevin lgg59identifyinghiddendriversoflowgradegliomatumorgrowth
AT rootdavid lgg59identifyinghiddendriversoflowgradegliomatumorgrowth
AT perskynicole lgg59identifyinghiddendriversoflowgradegliomatumorgrowth
AT boehmjesse lgg59identifyinghiddendriversoflowgradegliomatumorgrowth
AT bandopadhayaypratiti lgg59identifyinghiddendriversoflowgradegliomatumorgrowth
AT beroukhimrameen lgg59identifyinghiddendriversoflowgradegliomatumorgrowth